Filing Details
- Accession Number:
- 0001104659-23-087441
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-08-03 20:29:02
- Reporting Period:
- 2023-08-01
- Accepted Time:
- 2023-08-03 20:29:02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1657312 | Verona Pharma Plc | VRNA | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1627642 | David Zaccardelli | 3 More London Riverside London X0 SE1 2RE | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Disposition | 2023-08-01 | 105,944 | $2.68 | 16,781,392 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2023-08-02 | 73,704 | $2.59 | 16,707,688 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
- The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction entered into on March 24, 2022 solely with the intent to cover taxes in connection with the vesting of certain previously reported Restricted Share Units.
- The price reported represents the sale price of the ADSs divided by eight (8).
- Consists of (i) 5,911,840 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 738,980 ADSs); and (ii) 10,795,848 Ordinary Shares underlying 1,349,481 ADSs.
Billionaire Hedge Funds
